Literature DB >> 10759028

A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure.

L Cai1, B Struk, M D Adams, W Ji, T Haaf, H L Kang, S H Dho, X Xu, F Ringpfeil, J Nancarrow, S Zäch, L Schaen, M Stumm, T Niu, J Chung, K Lunze, B Verrecchia, L A Goldsmith, D Viljoen, L E Figuera, W Fuchs, M Lebwohl, J Uitto, R Richards, D Hohl, R Ramesar.   

Abstract

We have recently mapped the genetic defect underlying pseudoxanthoma elasticum (PXE), an inherited disorder characterized by progressive calcification of elastic fibers in skin, eye, and cardiovascular system, to chromosome 16p 13.1. Here we report further data on the fine-mapping and genomic structure of this locus. Haplotype analysis of informative PXE families narrowed the locus to an interval of less than 500 kb located between markers D16B9621 and D16S764. Three overlapping YAC clones were found to cover this region through YAC-STS content mapping. An overlapping BAC contig was then constructed to cover this interval and the surrounding region. About 80% of this chromosomal region has been fully sequenced using the BAC shotgun technique. Gene content and sequence analysis predicted four genes (MRP1, MRP6, PM5, and a novel transcript) and two pseudogenes (ARA and PKDI) within this interval. By screening a somatic cell hybrid panel we were able to precision-map the breakpoint of Cy185 and the starting point of a chromosomal duplication within 20 kb of BAC A962B4. The present data further refine the localization of PXE, provide additional physical cloning resources, and will aid in the eventual identification of the genetic defect causing PXE.

Entities:  

Mesh:

Year:  2000        PMID: 10759028     DOI: 10.1007/s001090000079

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  20 in total

1.  Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter.

Authors:  F Ringpfeil; M G Lebwohl; A M Christiano; J Uitto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Can complex genetic diseases be solved? (and a PS on PXE).

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 3.  Pseudoxanthoma elasticum revealed.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 4.  ABCC6 as a target in pseudoxanthoma elasticum.

Authors:  András Váradi; Zalán Szabó; Viola Pomozi; Hugues de Boussac; Krisztina Fülöp; Tamás Arányi
Journal:  Curr Drug Targets       Date:  2011-05       Impact factor: 3.465

Review 5.  [Pseudoxanthoma elasticum].

Authors:  M S Ladewig; C Götting; C Szliska; P C Issa; H-M Helb; I Bedenicki; H P N Scholl; F G Holz
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

6.  Development of a rapid, reliable genetic test for pseudoxanthoma elasticum.

Authors:  Yanggu Shi; Sharon F Terry; Patrick F Terry; Lionel G Bercovitch; Gary F Gerard
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

Review 7.  Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.

Authors:  Qiaoli Li; Qiujie Jiang; Ellen Pfendner; András Váradi; Jouni Uitto
Journal:  Exp Dermatol       Date:  2008-10-22       Impact factor: 3.960

8.  The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2016-07-22

Review 9.  Heritable ectopic mineralization disorders: the paradigm of pseudoxanthoma elasticum.

Authors:  Qiaoli Li; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2012-11-15       Impact factor: 8.551

10.  The mineralization phenotype in Abcc6 ( -/- ) mice is affected by Ggcx gene deficiency and genetic background--a model for pseudoxanthoma elasticum.

Authors:  Qiaoli Li; Jouni Uitto
Journal:  J Mol Med (Berl)       Date:  2009-09-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.